US Patent Issued to VALO THERAPEUTICS on May 12 for "Modified oncolytic adenoviruses" (Finnish Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,935, issued on May 12, was assigned to VALO THERAPEUTICS OY (Helsinki).

"Modified oncolytic adenoviruses" was invented by Tuuli Ranki (Helsinki), Sari Pesonen (Helsinki), Petri Priha (Helsinki), Erkko Ylosmaki (Helsinki), Vincenzo Cerullo (Helsinki) and Beatriz Martins (Helsinki).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention concerns a modified replication competent, oncolytic adenovirus; a pharmaceutical composition comprising same; and a method of treating cancer using same."

The patent was filed on March 19, 2019, under Application No. 17/040,017.

*For further information, including images, charts and tables, please visit: http://p...